SPO Global (SPO Global) Institutional Ownership : 0.72% (As of Jun. 20, 2024)

View and export this data going back to . Start your Free Trial

What is SPO Global Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, SPO Global's institutional ownership is 0.72%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, SPO Global's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, SPO Global's Float Percentage Of Total Shares Outstanding is 100.00%.

SPO Global Institutional Ownership Historical Data

The historical data trend for SPO Global's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SPO Global Institutional Ownership Chart

SPO Global Historical Data

The historical data trend for SPO Global can be seen below:

	2016-05-31
Institutional Ownership	0.72

SPO Global Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

SPO Global (SPO Global) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » SPO Global Inc (OTCPK:SPOM) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jinan Pharma Valley, 27th Floor Block A J, Shandong, CHN, 33634

Website

http://www.gerpanghealthcare.com

SPO Global Inc is a holding company whose strategic plan is to acquire interests in emerging young businesses and provide financing, advice and guidance to assist them in realizing their potential. The Company is implementing an acquisition roll-up model of acquiring sales, marketing, and manufacturing businesses. The business scope of the company includes bio-pharmaceutical Research and development, development and sales of medical informatization software, medical high-tech introduction, production and sales of medical quality supplies, dietary supplements, and medicine, as well as agents and sales of medical equipment supplies.

Executives

Jeffrey Louis Feuer	officer: Chief Financial Officer	21860 BURBANK BLVD SUITE 380, WOODLAND HILLS CA 91367
Richard H Ryan	officer: Chief Operating Officer	21860 BURBANK BLVD., NORTH BUILDING SUITE 380, WOODLAND HILLS CA 91367
Michael Braunold	director, officer: Chief Executive Officer	C/O AUBIENT CORP, 1033 BECON ST, BROOKLINE MA 02446
Sidney Braun	director	SUITE 404, 6711 MISSISSAUGA ROAD, MISSISSAUGA A6 L5N 2W3
Pauline Dorfman	director	183 REINER ROAD, TORONTO A6 M3H 2L8
Israel Sarussi	10 percent owner, officer: Chief Technology Officer	C/O SPO, SUITE 380, 21860 BURBANK BLVD., WOODLAND HILLS CA 91367